Proportion of isolates with decreased susceptibility or resistance in Germany
Germany: Proportion of isolates with decreased susceptibility or resistance was 1 in 2018. ◆ Volatile
Proportion of isolates with decreased susceptibility or resistance in Germany, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
Germany recorded 1 for proportion of isolates with decreased susceptibility or resistance in 2018.
The figure is down 55.0% over ten years.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in Germany peaked at 12.87 in 2013 and was at its lowest, 0, in 2014.
That places Germany 12th out of 27 countries with data for 2018, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with decreased susceptibility or resistance in Germany, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 2.22 | — |
| 2010 | 11.93 | +436.7% |
| 2011 | 10.19 | -14.6% |
| 2012 | 5.66 | -44.4% |
| 2013 | 12.87 | +127.4% |
| 2014 | 0 | -100.0% |
| 2015 | 1.83 | — |
| 2016 | 6.42 | +250.0% |
| 2017 | 1 | -84.4% |
| 2018 | 1 | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.22 | 2.22 | 2.22 | 1 |
| 2010s | 5.66 | 0 | 12.87 | 9 |
Countries ranked near Germany
- 9 Sweden 1.5 compare
- 10 Poland 1.4 compare
- 11 United Kingdom of Great Britain and Northern Ireland 1.2 compare
- 13 Canada 0.5445 compare
- 14 United States of America 0.2907 compare
- 15 Estonia 0
- 15 Malta 0 compare
- 15 France 0 compare
- 15 Netherlands 0 compare
- 15 Slovakia 0 compare
- 15 Slovenia 0 compare
- 15 Iceland 0
- 15 Latvia 0 compare
- 15 Portugal 0 compare
- 15 Ireland 0 compare
- 15 Norway 0 compare
- 15 Côte d'Ivoire 0
- 15 Denmark 0 compare
More health data for Germany
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9955 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,164 deaths per 1,000 people (2090)
- Number of infants who die before age 1 368 deaths (2100)
- Population ages 30-34, female, annual growth rate -4.03 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0291 units per person (2025)
- Population ages 30-34, male, annual growth rate -3.65 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0313 units per person (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in Germany?
- Proportion of isolates with decreased susceptibility or resistance in Germany was 1 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Germany?
- The highest recorded value was 12.87 in 2013.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Germany?
- The lowest recorded value was 0 in 2014.
- How does Germany rank for proportion of isolates with decreased susceptibility or resistance?
- Germany ranks 12th out of 27 countries with data for 2018.
- Is proportion of isolates with decreased susceptibility or resistance rising or falling in Germany?
- Over the last ten years it is down 55.0%. The long-run trend across the full record is volatile.
- Where does this Germany data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).